ANDREW TIMPSON
@Silverarc Capital Management, Llc
Latest period2024 - Q3ReportedManaged Assets$445.291MTotal holdings69
Assets growth rate5.06%Assets growth rate (2-Q avg)11.39%Continuous growth in asset value6 quarters
Portfolio positions
This chart displays the top 10 holdings in Silverarc Capital Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Silverarc Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 6 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 445.291M in assets, with a quarterly growth rate of 5.06% and a 2-quarter average growth rate of 11.39%. The portfolio is managed by ANDREW TIMPSON, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
WVEWave Life Sciences Ltd
| 1.16% | $5.146M 627,552 shares@ $8.2 avg price | Increased 26.66% |
IRONDisc Medicine Inc
| 1.15% | $5.104M 103,862 shares@ $49.15 avg price | Increased 2.65% |
BHVNBiohaven Ltd
| 1.12% | $4.975M 99,566 shares@ $49.97 avg price | Decreased -0.43% |
CLDXCelldex Therapeutics Inc New
| 1.11% | $4.929M 145,000 shares@ $33.99 avg price | Decreased -61.32% |
LBPHLongboard Pharmaceuticals In
| 0.94% | $4.145M 124,353 shares@ $33.33 avg price | Increased 1.23% |
BIIBBiogen Inc
| 0.87% | $3.865M 19,940 shares@ $193.85 avg price | Increased 2.97% |
PRAXPraxis Precision Medicines I
| 0.87% | $3.858M 67,045 shares@ $57.54 avg price | Decreased -0.37% |
MRSNMersana Therapeutics Inc
| 0.75% | $3.315M 1.754M shares@ $1.9 avg price | Decreased -29.85% |
MODDModular Med Inc
| 0.73% | $3.24M 1.44M shares@ $2.25 avg price | Increased 60% |
SLDBSolid Biosciences Inc
| 0.72% | $3.19M 457,739 shares@ $6.98 avg price | Decreased -3.22% |